A new report published by the ABPI and Vermilion Life Sciences this week identifies a number of stakeholder issues and proposed actions for the UK in reengineering medicines development.
The report, Reengineering medicines development: Summary output of a stakeholder roundtable on cost-effective development of affordable innovative medicines is the output of a roundtable event on reengineering medicines development held on 4 March which reviewed proposals from Reengineering medicines development: A stakeholder discussion document for cost-effective development of affordable innovative medicines. Multiple stakeholders including regulatory agencies, Health Technology Assessment (HTA) bodies, patient groups, clinicians, academia and pharmaceutical companies discussed challenges in affordability and duration of medicines development, that lead to delays in access due to cost-effectiveness concerns, and ways to overcome these....
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.